Attovia Therapeutics, Inc. · NASDAQ:ATTO
Deep Track Biotechnology Master Fund, Ltd. converted 1,957,138 Attovia Therapeutics, Inc. shares (Form 4)
Traded Aug 6, 2026 · Filed Aug 10, 2026
On Aug 6, 2026, Deep Track Biotechnology Master Fund, Ltd. (10% owner) converted 1,957,138 Attovia Therapeutics, Inc. shares, leaving 1,957,138 shares. Filed Aug 10, 2026 (Form 4).
- Converted
- 1,957,138 shares
- Holding after
- 1,957,138 shares
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | Conversion | 1,957,138 | 1,957,138 | Direct |
Source
Related
- Attovia Therapeutics, Inc.
- Deep Track Biotechnology Master Fund, Ltd.
- Attovia Therapeutics, Inc. shareholders
- Form 4/A · Walsh Colin · Aug 28, 2026
- Form 4/A · Goldman Sachs Asset Management, L.P. · Aug 28, 2026
- Form 4 · Goldman Sachs & Co. LLC · Aug 13, 2026
- Schedule 13G · Deep Track Capital, LP · Aug 12, 2026
- Schedule 13D · Frazier Life Sciences XI, L.P. · Aug 11, 2026